Literature DB >> 12209082

Exercise in elite summer athletes: Challenges for diagnosis.

Karen Holzer1, Sandra D Anderson, Jo Douglass.   

Abstract

BACKGROUND: There is a high prevalence of asthma and exercise-induced bronchoconstriction (EIB) in elite athletes when the diagnosis is based on symptoms and medication use. Objective measurements are now required by some sporting bodies to support a diagnosis of asthma or EIB to justify use of beta-agonists. Such measurements could include bronchial provocation with methacholine, with eucapnic voluntary hyperpnea (EVH) of dry air (a surrogate for exercise), or both.
OBJECTIVE: The aim of the study was to investigate the relationship between asthma symptoms and responses to methacholine and the EVH challenge in a group of unselected elite summer-sport athletes. The outcome would be to inform practitioners of a suitable objective approach to identifying those with asthma and EIB.
METHODS: Fifty elite summer-sport athletes with or without asthma were recruited from sporting teams and sports medicine centers throughout Melbourne, Australia. All subjects completed a respiratory questionnaire and, on separate days, underwent a bronchoprovocation challenge test with methacholine and EVH.
RESULTS: Forty-two subjects reported one or more respiratory symptoms in the past year, 9 had positive methacholine challenge results (mean PD(20) of 1.69 +/- 2.05 micromol), and 25 had positive EVH challenge results (mean fall in FEV(1) of 25.4% +/- 15%). Although all subjects with positive methacholine challenge results had positive EVH challenge results, methacholine had a negative predictive value of only 61% and a sensitivity of 36% for identifying those responsive to EVH.
CONCLUSION: These findings suggest that the pathogenesis of EIB in elite athletes might be different from that of asthma, and as such, neither symptoms nor the methacholine challenge test should be used exclusively for identifying EIB.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209082     DOI: 10.1067/mai.2002.127784

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  37 in total

1.  Airway immunopathology of asthma with exercise-induced bronchoconstriction.

Authors:  Teal S Hallstrand; Mark W Moody; Moira L Aitken; William R Henderson
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

2.  Screening for exercise-induced bronchoconstriction in college athletes.

Authors:  Jonathan P Parsons; David Cosmar; Gary Phillips; Christopher Kaeding; Thomas M Best; John G Mastronarde
Journal:  J Asthma       Date:  2012-01-25       Impact factor: 2.515

Review 3.  Making the diagnosis of asthma in the athlete.

Authors:  Chris Randolph
Journal:  Clin Rev Allergy Immunol       Date:  2005-10       Impact factor: 8.667

4.  Screening elite winter athletes for exercise induced asthma: a comparison of three challenge methods.

Authors:  J W Dickinson; G P Whyte; A K McConnell; M G Harries
Journal:  Br J Sports Med       Date:  2006-02       Impact factor: 13.800

5.  Exercise induced bronchoconstriction in elite athletes: measuring the fall.

Authors:  K Holzer; J A Douglass
Journal:  Thorax       Date:  2006-02       Impact factor: 9.139

Review 6.  Diagnostic exercise challenge testing.

Authors:  Christopher Randolph
Journal:  Curr Allergy Asthma Rep       Date:  2011-12       Impact factor: 4.806

Review 7.  Methods for "indirect" challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols.

Authors:  Sandra D Anderson; John D Brannan
Journal:  Clin Rev Allergy Immunol       Date:  2003-02       Impact factor: 8.667

Review 8.  Epithelial regulation of eicosanoid production in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William R Henderson; William A Altemeier; Michael H Gelb
Journal:  Pulm Pharmacol Ther       Date:  2012-12       Impact factor: 3.410

9.  Imitators of exercise-induced bronchoconstriction.

Authors:  Pnina Weiss; Kenneth W Rundell
Journal:  Allergy Asthma Clin Immunol       Date:  2009-11-17       Impact factor: 3.406

10.  Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypes.

Authors:  Teal S Hallstrand; Mark M Wurfel; Ying Lai; Zhanglin Ni; Michael H Gelb; William A Altemeier; Richard P Beyer; Moira L Aitken; William R Henderson
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.